Almac Group is now providing fluid-bed processing and encapsulation services from its UK development and commercial manufacturing facilities.   Multiparticulate systems, including pellets, beads, granules and mini-tablets, are typically formulated to optimize drug performance, enhance patient tolerance and safety and extend patent protection. As development and scale-up of these dosage forms can be challenging, clients are seeking technical expertise and equipment capabilities that provide sca...